ugottafriend.com
My Roller Coaster Life: August 2015
http://www.ugottafriend.com/2015_08_01_archive.html
Saturday, August 29, 2015. Hurricane Katrina: 10 Years. I was going to post a heavy blog about the 10 year remembrance of Hurricane Katrina, which gutted my state's entire beautiful coastline. But I've decided not to do that. Most of us have seen plenty of images. Some of us saw the nightmare firsthand. But more importantly, we lived through. No matter where life takes me, it will always be my home. Wednesday, August 26, 2015. I Have Systemic Disease - An Open Letter of Awareness. I wanted to share all o...
strongbridgebio.com
Primary Periodic Paralysis - Strongbridge Biopharma
http://www.strongbridgebio.com/therapeutic-focus/primary-periodic-paralysis
Endogenous Cushing’s Syndrome. Key Publications and Posters. Events, Presentations, and Publications. Key Publications and Posters. Stock Quote and Chart. Cortendo AB 2016 Annual General Meeting. Cortendo plc Exchange Offer. Cross-Border Transaction Depositary Receipt. Committee Charters and Composition. IR and Media Contacts. In medical terms, primary periodic paralysis is referred to as a spectrum of chronic genetic, neuromuscular disorders with autosomal dominant inheritance. In clinical studies, the ...
strongbridgebio.com
Rare Disease Portfolio - Strongbridge Biopharma
http://www.strongbridgebio.com/products
Endogenous Cushing’s Syndrome. Key Publications and Posters. Events, Presentations, and Publications. Key Publications and Posters. Stock Quote and Chart. Cortendo AB 2016 Annual General Meeting. Cortendo plc Exchange Offer. Cross-Border Transaction Depositary Receipt. Committee Charters and Composition. IR and Media Contacts. Strongbridge is dedicated to bridging treatment gaps in rare diseases like primary periodic paralysis, endogenous Cushing’s syndrome and acromegaly. A Growing Portfolio of Products.
strongbridgebio.com
KEVEYIS®: Treatment for Primary Periodic Paralysis - Strongbridge Biopharma
http://www.strongbridgebio.com/products/keveyis
Endogenous Cushing’s Syndrome. Key Publications and Posters. Events, Presentations, and Publications. Key Publications and Posters. Stock Quote and Chart. Cortendo AB 2016 Annual General Meeting. Cortendo plc Exchange Offer. Cross-Border Transaction Depositary Receipt. Committee Charters and Composition. IR and Media Contacts. Treatment for Primary Periodic Paralysis. KEVEYIS Has Been Proven to Reduce Attacks in 2 Clinical Studies vs Placebo. Results in Study 1:. Results in Study 2:. The most common adve...
fightinghkpp.blogspot.com
The Fight Against Hypokalemic Periodic Paralysis: Big News for HKPP Patients: FDA Approves dichlorphenamide (KEVEYIS) for treatment of Primary Periodic Paralyses
http://fightinghkpp.blogspot.com/2015/08/big-news-for-hkpp-patients-fda-approves.html
Thursday, August 13, 2015. Big News for HKPP Patients: FDA Approves dichlorphenamide (KEVEYIS) for treatment of Primary Periodic Paralyses. I am so behind on everything, I am just now getting to this news:. Earlier this week, the FDA approved carbonic anhydrase inhibitor dichlorphenamide (KEVEYIS) for the treatment of all forms of Primary (Familial) Periodic Paralysis. Thanks to the Muscular Dystrophy Association, other Periodic Paralysis researchers, and study participants who made this possible. I am ...
strongbridgebio.com
Strongbridge Biopharma Cushing’s Syndrome & Acromegaly
http://www.strongbridgebio.com/therapeutic-focus
Endogenous Cushing’s Syndrome. Key Publications and Posters. Events, Presentations, and Publications. Key Publications and Posters. Stock Quote and Chart. Cortendo AB 2016 Annual General Meeting. Cortendo plc Exchange Offer. Cross-Border Transaction Depositary Receipt. Committee Charters and Composition. IR and Media Contacts. Strongbridge Biopharma is building a portfolio of vertical, therapeutically-aligned rare disease franchises. Learn more about primary periodic paralysis. Endogenous Cushing’s syndr...
ugottafriend.com
My Roller Coaster Life: FDA Approves Drug To Treat Familial Periodic Paralysis
http://www.ugottafriend.com/2015/08/fda-approves-drug-to-treat-familial.html
Thursday, August 13, 2015. FDA Approves Drug To Treat Familial Periodic Paralysis. I am so behind on everything, I am just now getting to this news:. Earlier this week, the FDA approved carbonic anhydrase inhibitor dichlorphenamide (KEVEYIS) for the treatment of all forms of Primary (Familial) Periodic Paralysis. Thanks to the Muscular Dystrophy Association, other Periodic Paralysis researchers, and study participants who made this possible. Drug website is here: http:/ www.keveyis.com/. I am blessed de...